However, this standard NPO protocol assumes normal stomach emptying
Study author Patricia Rodriguez, PhD, MPH, principal applied scientist at Truveta, which partly funded the study, noted the following additional highlights of the studys findings, to MNT : Patients on tirzepatide were over two times more likely to experience 10% weight loss and three times more likely to experience 15% weight loss within a year, compared to patients on semaglutide
Newer research has also been investigating whether a higher dose of Wegovy can help people with obesity who arent able to achieve their weight loss goals on the current approved doses
It is studied in non-clinical research contexts involving gastric peptide fragments, matrix remodeling, and tissue-response signaling
This can soon cause tiredness and fatigue